Correlative and Spatial Biomarker Analysis of a Phase 1/2b Study to Evaluate Pepinemab in Combination with Pembrolizumab for First-Line Treatment of Patients with Recurrent or Metastatic Head and Neck Cancer.
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined